Mechanisms of Progression of Myeloid Preleukemia to Transformed Myeloid Leukemia in Children with Down Syndrome.

Journal: Cancer Cell

Published: 2019-07-09

DOI: 10.1016/j.ccell.2019.06.007

Affiliations: 22

Authors: 34

Go to article
Institutions Share
NIHR Oxford Biomedical Research Centre (OxBRC), United Kingdom (UK) 0.25
Medical Faculty, MLU, Germany 0.12
Department of Paediatric Haematology and Oncology, MHH, Germany 0.10
Max Planck Institute for Molecular Genetics (MPI-MG), Germany 0.10
LICR Brussels Branch, Belgium 0.06
Department of Pathology and Tumor Biology, Kyoto University, Japan 0.04
Division of Hematology and Oncology, NU, United States of America (USA) 0.03
Institute of Physiology and Medicine, Jobu University, Japan 0.03
Sanger Institute's Cancer Genome Project, United Kingdom (UK) 0.03
Clinic for Pediatrics III, UDE, Germany 0.03
Graduate School / School of Medicine, Hirosaki University, Japan 0.03
Department of Pediatrics, SUMS, Japan 0.03
Department of Hematology, St. Jude, United States of America (USA) 0.03
Department of Hematology, OUH, United Kingdom (UK) 0.01
Department of Epidemiology and Biostatistics, MSKCC, United States of America (USA) 0.01
Cancer Biology and Genetics Program (CBG), MSKCC, United States of America (USA) 0.01
School of Medicine, Wayne State University, United States of America (USA) 0.01
Structural Genomics Consortium (SGC Oxford), United Kingdom (UK) 0.01
Oxford Department of Paediatrics, United Kingdom (UK) 0.01
Center for Hematology and Regenerative Medicine (HERM), KI, Sweden 0.01
Children's Hospital of Michigan, DMC, United States of America (USA) 0.01